期刊文献+

自体灭活T细胞免疫后诱导Treg下调的机制

Mechanism of Treg down-regulation by immunization with attenuated activated autologous T cells
下载PDF
导出
摘要 目的探讨自体灭活T细胞免疫注射后诱导体内调节性T细胞(Treg)下调的机制。方法自体T细胞体外用刀豆蛋白(ConA)刺激活化,照射灭活T细胞给小鼠进行皮下和腹腔免疫(每只小鼠5×106/次),每隔5 d免疫一次,免疫3次后检测小鼠体内Treg的数量及功能;对照组小鼠皮下注射PBS。ELISA法检测血清中抗鼠CD25抗体。免疫小鼠血清分离后经尾静脉注入未免疫小鼠体内,检测受体小鼠Treg的数量及功能变化。结果免疫小鼠体内CD4+CD25+Foxp3+Treg数量较对照组减少(P<0.01),抑制功能也显著降低(P<0.01),但血清中抗CD25的抗体增加(P<0.01)。正常小鼠接受免疫小鼠血清后,Treg的数量和抑制功能下调(P<0.01)。结论采用ConA活化的自体灭活T细胞免疫,可诱导抗CD25抗体增加,进而减少体内CD4+CD25+Foxp3+Treg细胞数量和功能。 Objective To explore the mechanism of down-regulation of regulatory T cells(Treg) by immunization with attenuated activated autologous T cells. Methods Autologous T cells were activated with ConA in vitro.Mice were immunized subcutaneously and intraperitoneally every 5 days for 3 times(5×10^6 per time for each mouse),and the number and function of Treg were examined.PBS was subcutaneously injected for control group.Serum level of anti-mouse CD25 antibody was measured by ELISA.The number and function of Treg was detected by serum adoptive transfer and proliferation and inhibition assays. Results Compared with control group,there were less CD4^+CD25^+Foxp3^+Treg in the mice after immunization(P〈0.01),the immunosuppression ability decreased(P〈0.01),and the level of anti-CD25 antibody increased(P〈0.01).Adoptive transfer of serum from immunized mice to naive mice led to a significant decrease in Treg population and function in recipient mice(P〈0.01). Conclusion Immunization with attenuated activated autologous T cells induces more anti-CD25 antibody,which may further down-regulate CD4^+CD25^+Foxp3^+ Treg expansion and function in vivo.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2009年第10期1148-1151,1156,共5页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家自然科学基金(30671945 30872990) 上海市科委基金(08ZR1412400)~~
关键词 自体T细胞 调节性T细胞 CD4 CD25 FOXP3 抗体 小鼠 autologous T cell regulatory T cell CD4 CD25 Foxp3 antibody mouse
  • 相关文献

参考文献16

  • 1Wang HY, Wang RF. Regulatory T cells and cancer[J]. Curr Opin Immunol, 2007, 19(2) : 217 -223.
  • 2Miyara M, Sakaguchi S. Natural regulatory T eells: mechanisms of suppressionl J]. Tends Mol Med, 2007, 13(3) : 108 -116.
  • 3Sakaguchi S, Ono M, Setoquchi R, et al. Foxp3 + CD25 + CD4 + natural regulatory T cells in dominant self-tolerance and autoimmune disease[J]. Immunol Rev, 2006, 212(8): 8-27.
  • 4Danese S, Rutella S. The Janus face of CD25 + CD4 + regulatory T cells in cancer and autoimmunity [.1]. Curr Med Chem, 2007,14 (6) : 649 - 666.
  • 5Levings MK, Allan S, Hennezel E, et al. Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity [J]. Adv Immunol, 2006, 92(1): 119 -155.
  • 6Toda A, Pieeirilla CA. Development and function of naturally occurring CD4 + CD25 + regulatory T cells [ J ]. J Leukoc Biol, 2006, 80(3) : 458 -470.
  • 7Mudd PA, Teague BN, Farris AD. Regulatory T cells and systemic lupus erythematosus[ J]. Scand J Immunol, 2006, 64 (3) : 211 - 218.
  • 8Sakaguchi S, Sakaguchi N, Shimizu J, et al. Immunologic tolerance maintained by CD25 + CD4 + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance [ J]. Immunol Rev, 2001, 182 : 18 - 32.
  • 9Antony PA, Restifo NP. Do CD4 + CD25 + immunoregulatory T cells hinder tumor immunotherapy [ J ] ? J Immunother, 2002, 25 ( 3 ) : 202 - 206.
  • 10Comes A, Rosso O, Orengo AM, et al. CD25 + regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21- secreting cellular vaccine [ J ]. J Immunol, 2006,176 ( 3 ) : 1750 - 1758.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部